Videos

Hugh Taylor, MD, welcomes ACOG's new guidance allowing clinical, nonsurgical diagnosis of endometriosis and emphasizes it is a systemic disease affecting the whole body.

Amber Watters, MD, MS, explains that emergent delivery after external cephalic version is exceedingly rare and fits within existing protocols, and outlines how to build a version program.

Positively Pregnant translates cycle day and cycle length research into individualized pregnancy test sensitivity estimates, according to Alexandra C. Sundermann, MD, PhD.

Kevin Ault, MD, FACOG, explains that all four vaccines in ACOG's 2026-27 guidance carry direct newborn benefit and that prenatal conversations ease downstream pediatric vaccine discussions.

Kevin Ault, MD, FACOG, emphasizes that obstetric clinicians are patients' most trusted vaccine information source, making maternal COVID-19 counseling a high-value opportunity.

In "Improving Shared Decision-Making in Endometriosis Care," the panel opens Section 3 by asking why medical management still lags in everyday practice.

Amber Watters, MD, MS, explains how the ASA's statement encourages obstetric units to integrate neuraxial anesthesia into a formal external cephalic version process.

David Shalowitz, MD, MSHP, describes how OB-GYNs can collaborate with non-gynecologic surgeons to extend salpingectomy and reduce ovarian cancer risk during other abdominal procedures.

Positively Pregnant, built on PRESTO data, gives patients day-specific, evidence-based estimates of home pregnancy test accuracy by cycle timing, as Alexandra C. Sundermann, MD, PhD, explains in this video.

Kevin Ault, MD, FACOG, explains that maternal COVID-19 and influenza vaccination protects newborns and reduces severe maternal illness, stillbirth, and prematurity.

Kevin Ault, MD, FACOG, explains ACOG's extension of the maternal RSV vaccine window to March 1 and the role of passive immunity in protecting newborns.

David Shalowitz, MD, MSHP, explains that stronger effectiveness and safety data in average-risk patients drove ACOG's strengthened salpingectomy recommendation.

In "Monitoring Safety and Symptom Relief During Endometriosis Therapy," Dr. Davitt details the practical monitoring plan he follows once a patient begins therapy.

This episode, "Add-Back Therapy: Balancing Efficacy and Safety in Endometriosis," features Dr. Davitt reviewing 12-month efficacy and safety data on add-back therapy.

Experts weigh GLP-1 therapy's promise for PMOS against the risks of overly rapid weight loss in teens.

Experts break down which labs actually change PMOS management and how to avoid diagnostic pitfalls.

Experts outline when primary care should manage PMOS versus refer, and why insulin resistance matters.

Experts detail how PMOS diagnostic criteria differ in adolescents, where ovarian ultrasound doesn't apply.

Heather Appelbaum, MD, FACOG, Melanie Cree, MD, PhD, and Michelle Maresca, MD, react to the renaming of PCOS to PMOS in the first of 5 episodes of this Special Report series discussing the new name.

Alexis Totaro, MSN, RN, WHNP-c, CARN-AP, explains how to assess a struggling postpartum patient and execute a clinician-to-clinician warm handoff when escalation is needed.

Peptides are highly specific signaling molecules with a heterogeneous evidence base; clinical application in women's health is most established through metabolic pathways, according to Carrie Carda, MD, MMS, MHS.

Alexis Totaro, MSN, RN, WHNP-c, CARN-AP, outlines the criteria guiding the choice between outpatient counseling and emergency psychiatric care in the postpartum period.

Alexis Totaro, MSN, RN, WHNP-c, CARN-AP, explains how sleep behavior helps distinguish normal postpartum deprivation from an emerging psychiatric concern, and how to screen for psychosis.

Comprehensive, trend-based hormone testing grounded in patient history offers a more complete clinical picture than isolated screening—but no panel replaces the symptom conversation, says Carrie Carda, MD, MMS, MHS.

In "Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain," the panel reviews two-year outcomes from a major open-label extension trial.

In "Choosing Between Newer GnRH Antagonist Therapies for Endometriosis," Dr. Davitt compares two newer, FDA-approved options for treating endometriosis-associated pain.

Alexis Totaro, MSN, RN, WHNP-c, CARN-AP, explains that the clinical exam and knowledge of a patient's baseline are essential to catching early signs of postpartum psychosis and depression.

Rachel Meislin, MD, explains that anti-inflammatory reliever and maintenance strategies are standard in pulmonology and ob-gyns should recognize rather than disrupt them.

Bladder symptoms during IVF carry systemic diagnostic cues, and integrating bladder health screening and pelvic floor referrals into routine IVF consultation—before symptoms develop—improves patient outcomes, according to Aleece Fosnight, MSPAS, PA-C.

Rachel Meislin, MD, describes a structured asthma assessment that evaluates comorbidities, triggers, and adherence together.